Cargando…

Allergen-Specific Antibodies Regulate Secondary Allergen-Specific Immune Responses

Immunoglobulin E (IgE)-associated allergy is the most common immunologically-mediated hypersensensitivity disease. It is based on the production of IgE antibodies and T cell responses against per se innocuous antigens (i.e., allergens) and subsequent allergen-induced inflammation in genetically pre-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eckl-Dorna, Julia, Villazala-Merino, Sergio, Linhart, Birgit, Karaulov, Alexander V., Zhernov, Yury, Khaitov, Musa, Niederberger-Leppin, Verena, Valenta, Rudolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344431/ https://www.ncbi.nlm.nih.gov/pubmed/30705676 http://dx.doi.org/10.3389/fimmu.2018.03131

Ejemplares similares

Highly sensitive ELISA‐based assay for quantification of allergen‐specific IgE antibody levels
por: Karsonova, Antonina, et al.
Publicado: (2020)

Antibody Conjugates Bispecific for Pollen Allergens and ICAM-1 with Potential to Prevent Epithelial Allergen Transmigration and Rhinovirus Infection
por: Weichwald, Christina, et al.
Publicado: (2023)

Recombinant allergens for immunotherapy: state of the art
por: Zhernov, Yury, et al.
Publicado: (2019)

Trimolecular complex between major birch pollen allergen, Bet v 1, monoclonal allergen-specific human IgE and recombinant CD23
por: Selb, Regina, et al.
Publicado: (2014)

Poor association of allergen‐specific antibody, T‐ and B‐cell responses revealed with recombinant allergens and a CFSE dilution‐based assay
por: Eckl‐Dorna, J., et al.
Publicado: (2015)

Allergen Extracts for In Vivo Diagnosis and Treatment of Allergy: Is There a Future?
por: Valenta, Rudolf, et al.
Publicado: (2018)

Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1
por: Akinfenwa, Oluwatoyin, et al.
Publicado: (2021)

Tracing IgE-Producing Cells in Allergic Patients
por: Eckl-Dorna, Julia, et al.
Publicado: (2019)

Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG(4) response
por: Eckl-Dorna, Julia, et al.
Publicado: (2019)

Tracing Human IgE B Cell Antigen Receptor-Bearing Cells With a Monoclonal Anti-Human IgE Antibody That Specifically Recognizes Non-Receptor-Bound IgE
por: Zghaebi, Mohammed, et al.
Publicado: (2021)

Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy
por: Marth, Katharina, et al.
Publicado: (2014)

Next-Generation of Allergen-Specific Immunotherapies: Molecular Approaches
por: Curin, Mirela, et al.
Publicado: (2018)

Characterisation of recombinant CD23 in the trimeric complex with IgE and allergen
por: Selb, Regina Maria, et al.
Publicado: (2015)

Allergen-specific IgE levels and the ability of IgE-allergen complexes to cross-link determine the extent of CD23-mediated T-cell activation
por: Villazala-Merino, Sergio, et al.
Publicado: (2019)

Antibody conjugates bispecific for intercellular adhesion molecule 1 and allergen prevent migration of allergens through respiratory epithelial cell layers
por: Madritsch, Christoph, et al.
Publicado: (2015)

Recombinant allergen-based provocation testing()
por: Niederberger, Verena, et al.
Publicado: (2014)

A B Cell Epitope Peptide Derived from the Major Grass Pollen Allergen Phl p 1 Boosts Allergen-Specific Secondary Antibody Responses without Allergen-Specific T Cell Help
por: Narayanan, Meena, et al.
Publicado: (2017)

Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future
por: Valenta, Rudolf, et al.
Publicado: (2016)

Preventive Allergen-Specific Vaccination Against Allergy: Mission Possible?
por: Tulaeva, Inna, et al.
Publicado: (2020)

Passive immunization with allergen-specific IgG antibodies for treatment and prevention of allergy
por: Flicker, Sabine, et al.
Publicado: (2013)

Determination of IgE and IgG reactivity to more than 170 allergen molecules in paper-dried blood spots
por: Garib, Victoria, et al.
Publicado: (2018)

Effects of Nasal Corticosteroids on Boosts of Systemic Allergen-Specific IgE Production Induced by Nasal Allergen Exposure
por: Egger, Cornelia, et al.
Publicado: (2015)

Reduction in allergen-specific IgE binding as measured by microarray: A possible surrogate marker for effects of specific immunotherapy
por: Wollmann, Eva, et al.
Publicado: (2015)

From Allergen Molecules to Molecular Immunotherapy of Nut Allergy: A Hard Nut to Crack
por: Fuhrmann, Verena, et al.
Publicado: (2021)

Recombinant allergy vaccines based on allergen-derived B cell epitopes
por: Valenta, Rudolf, et al.
Publicado: (2017)

Albumins represent highly cross-reactive animal allergens
por: Liu, Zicheng, et al.
Publicado: (2023)

Past, present, and future of allergen immunotherapy vaccines
por: Dorofeeva, Yulia, et al.
Publicado: (2020)

A molecular model system based on human monoclonal allergen-specific IgE antibodies to study basophil activation
por: Najafi, Nazanin, et al.
Publicado: (2014)

Molecular Approaches for Diagnosis, Therapy and Prevention of Cow’s Milk Allergy
por: Linhart, Birgit, et al.
Publicado: (2019)

Novel vaccines for allergen-specific immunotherapy
por: Akinfenwa, Oluwatoyin, et al.
Publicado: (2021)

Milk Allergen Micro-Array (MAMA) for Refined Detection of Cow’s-Milk-Specific IgE Sensitization
por: Garib, Victoria, et al.
Publicado: (2023)

Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms
por: Campana, Raffaela, et al.
Publicado: (2018)

The Molecular Allergen Recognition Profile in China as Basis for Allergen-Specific Immunotherapy
por: D’souza, Nishelle, et al.
Publicado: (2021)

Allergen Microarray Indicates Pooideae Sensitization in Brazilian Grass Pollen Allergic Patients
por: Moreira, Priscila Ferreira de Sousa, et al.
Publicado: (2015)

Characterisation and culture of primary human nasal epithelial cells and the influence of Interferon-gamma
por: Waltl, Eva, et al.
Publicado: (2014)

Cumulative IgE-levels specific for respiratory allergens as biomarker to predict efficacy of anti-IgE-based treatment of severe asthma
por: Naumova, Veronika, et al.
Publicado: (2022)

Specific Antibodies for the Detection of Alternaria Allergens and the Identification of Cross-Reactive Antigens in Other Fungi
por: Twaroch, Teresa E., et al.
Publicado: (2016)

Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels—A pilot study
por: Eckl‐Dorna, J., et al.
Publicado: (2017)

Establishment of a cell culture model based on primary epithelial cells to investigate damage and repair of respiratory epithelial cells
por: Waltl, Eva E, et al.
Publicado: (2015)

The allergenic activity and clinical impact of individual IgE-antibody binding molecules from indoor allergen sources
por: Caraballo, Luis, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4nml20s4h4s9ng4t2kl8khfmu7